The correlation of left ventricular hypertrophy with the severity of atherosclerosis and embolic events

Journal of the Medical Association of Thailand

Volumn 88, Issue 2, 2005, Pages 156-161

  Wongpraparut, Nattawut ^a   Apiyasawat, Sirin ^a   Maraj, Suraj ^a   Jacobs, Larry E ^a   Kotler, Morris N ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Aortic atheroma; Left ventricular mass index; Stroke; Transesophageal echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STATINE DERIVATIVE;

AGED; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EMBOLISM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; SCORING SYSTEM; SMOKING; STATISTICAL SIGNIFICANCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; AORTIC DISEASES; ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED;

EID: 20444505313     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Gosse P, Dallocchio M. Left ventricular hypertrophy: epidemiological prognosis and associated critical factors. Eur Heart J 1993; 14 Suppl D: 16-21.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. Ann Intern Med 1989; 110: 101-7.
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
4. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
5. Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, et al. Left ventricular mass and risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA 1994; 272: 33-6.
6. Meyerowitz CB, Jacobs LE, Movsowitz H, Movsowitz C, Ioli A, Kotler MN. Left ventricular mass determined by transesophageal echocardiography and correlation with transthoracic echocardiography. Am J Card 1993; 72: 1085-6.
7. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-8.
8. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56: 56-64.
9. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol 1995; 25: 83-90.
10. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS. Effects of tobacco and non-tobacco cigarette smoking on the endothelium and platelets. Clin Pharmacol Ther 1985; 37: 529-33.
11. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-55.
12. Dovgan PS, Edwards JD, Zhan X, Wilde M, Agrawal DK. Cigarette smoking increases monocyte adherence to cultured endothelial cell monolayer. Biochem Biophys Res Commun 1994; 203: 929-34.
13. Nowak J, Murray JJ, Gates JA, FilzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987; 76: 6-14.
14. Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, et al. Smoking and plasma lipoprotein in man: Effects on low-density lipoprotein cholesterol levels and high-density lipoprotein subfraction distribution. Eur J Clin Invest 1993; 23: 630.
15. Steinberg D, Lewis A. Conner memorial lecture. Oxidative modification of LDL and atherosclerosis. Circulation 1997; 95: 1961-71.
16. O'Rouke MF. Vascular impedance: the relationship between pressure and flow. Arterial function in health and disease. Edinburgh: Churchill Livingstone, 1982: 94-132: 195-243.
17. Yin FCP, Liu Z. Arterial compliance: physiologic viewpoint. In: Westerhof N, Gross DR, editors. Vascular dynamics: physiologic perspective. New York: Plenum Press, 1989: 9-22.
18. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998; 32: 853-906.
19. Bostom AG, Lathrop L. Hyperhomocysteinemia in end stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997; 52: 10-20.
20. Zimmerman J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-58.
21. Diamond JR. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int Suppl 1991; 31: S29-34.
22. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000; 4: 35(4 Suppl 1): S117-31.